# US 8,278,462 B2 · Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,462 B2
- Document ID: US8278462B2
- Status: Granted
- Kind: B2
- Application number: 12/712,958
- Filed: 2010-02-25
- Published: 2010-10-28
- Granted: 2012-10-02
- Earliest claimed: 2002-12-09
- Assignees: Bristol-Myers Squibb Company
- Inventors: Truc Chi Vu; David B. Brzozowski; Rita Fox; Jollie Duaine Godfrey, Jr.; Ronald L. Hanson; Sergei V. Kolotuchin; John A. Mazzullo; Ramesh N. Patel; Jianji Wang; Kwok Wong; Jurong Yu; Jason J. Zhu; David R. Magnin; David J. Augeri; Lawrence G. Hamann
- Web page: https://patentgrep.com/patent/US8278462B2

## CPC

- C07C 69/757: having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, [IMAGE cpc-sch-C07C-0958.gif] groups,[IMAGE cpc-sch-C07C-0959.gif] groups, or[IMAGE cpc-sch-C07C-0960.gif] in the acid moiety
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 37/02: Immunomodulators
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 62/06: polycyclic
- C07C 69/635: containing rings in the acid moiety
- C07C 69/675: of saturated hydroxy-carboxylic acids
- C07C 229/28: the carbon skeleton being saturated and containing rings
- C07C 271/22: to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
- C07D 207/22: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D 209/52: condensed with a ring other than six-membered
- C07C 2603/74: Adamantanes
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Methods and compounds for production of cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV are provided.

## Claims

### Claim 1

A compound M″

### Claim 2 (depends on 1)

A method for making the compound M″ according to claim 1, the method comprising
(a) treating compound L
with hydrochloric acid to provide compound L′
(b) treating compound L′ with sodium hydroxide to provide compound M′
(c) treating compound M′ with water to provide compound M″.

### Claim 3 (depends on 2)

The method according to claim 2, wherein compound L is provided by a method comprising:
treating compound K
with trifluoroacetic anhydride in the presence of pyridine or triethylamine followed by treatment with a strong base to provide compound L.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the strong base is sodium hydroxide, lithium hydroxide or potassium hydroxide.
